Who invested in Cardioxyl Pharmaceuticals?
Cardioxyl Pharmaceuticals's investors include New Enterprise Associates, The Aurora Funds, OrbiMed and Osage University Partners.
United States · Series B startup
4 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$67Mraised across 4 rounds since 2006, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by cardioxyl.comSEC filing: $28M sold, first sale Oct 2012
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Jul 2010
No investor was named in the report.
From a historical funding recordSEC filing: $9.0M sold, first sale Aug 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Cardioxyl Pharmaceuticals's investors include New Enterprise Associates, The Aurora Funds, OrbiMed and Osage University Partners.
Cardioxyl Pharmaceuticals has raised $67M across 4 rounds since 2006.
Cardioxyl Pharmaceuticals's most recent round was a Series B of $28M in Nov 2012.
Its most recent round, $28M in Nov 2012, is also its largest on record.
Cardioxyl Pharmaceuticals's first round on record, in Dec 2006, was backed by New Enterprise Associates and The Aurora Funds.
Cardioxyl Pharmaceuticals's latest named round is a Series B, in Nov 2012.
Cardioxyl Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.